Report cover image

Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use, By Region – Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Jul 01, 2025
Length 129 Pages
SKU # PLRS20324596

Description

The point of care (POC) lipid test market size is expected to reach USD 1,392.97 million by 2034, according to a new study by Polaris Market Research. The report “Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use, By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

A point of care (POC) lipid test is a diagnostic tool used to measure lipid levels such as total cholesterol, HDL, LDL, and triglycerides, directly at the site of patient care. It provides rapid results from a small blood sample, often within minutes, without needing a central laboratory.

Governments and health organizations are promoting routine cholesterol screening as part of national health programs aimed at reducing heart disease. Many public health campaigns emphasize early detection and regular lipid testing, especially for people with risk factors such as obesity, diabetes, or a family history of cardiovascular conditions. Some countries further provide funding or incentives for point of care testing in community clinics and pharmacies. These efforts are helping to normalize and increase the use of POC lipid tests across populations. Strong policy support and funding further accelerate the growth and accessibility of the market.

There is a growing shift from reactive to preventive healthcare, where the goal is to catch diseases early or avoid them altogether. Lipid testing is a key tool in identifying risks for heart disease and related conditions before symptoms appear. Point of care testing devices make this process faster and easier, encouraging more frequent testing, especially in high-risk groups. These tests support better health outcomes by enabling early intervention and lifestyle changes. The demand for convenient lipid testing options is increasing significantly as awareness of preventive care rises among both patients and providers, thereby driving the POC lipid test market growth.

Point of Care Lipid Test Market Report Highlights

In 2024, the consumables segment dominated with the largest share as these items are essential for every test and need to be replaced regularly, fueling consistent demand.

The hypertriglyceridemia segment is expected to experience significant growth during the forecast period as hypertriglyceridemia is becoming increasingly common due to rising obesity rates.

The market in North America dominated with the largest share in 2024, driven by rising cardiovascular disease prevalence, an aging population, and well-established healthcare infrastructure.

The Asia Pacific market is projected to witness substantial growth during the forecast period, driven by increasing cardiovascular disease cases, growing health awareness, and expanding access to healthcare services.

A few global key market players are Abbott Laboratories; Callegari Srl; F. Hoffmann-La Roche Ltd.; Menarini Group; MiCoBio; Nova Biomedical; SD Biosensor, Inc.; Sinocare Inc.; and VivaChek Biotech (Hangzhou) Co., Ltd.

Polaris Market Research has segmented the point of care lipid test market report on the basis of product, application, disease indication, end use, and region:

By Product (Revenue – USD Million, 2020–2034)

Instruments

Consumables

By Application (Revenue – USD Million, 2020–2034)

Hyperlipidemia

Hypertriglyceridemia

Tangier Disease

Hyperlipoproteinemia

Familial Hypercholesterolemia

Others

By Disease Indication (Revenue – USD Million, 2020–2034)

Lipid and Lipoprotein Disorders

Atherosclerosis

Liver and Renal Diseases

Diabetes Mellitus

Others

By End Use (Revenue – USD Million, 2020–2034)

Hospitals

Clinics

Research and Diagnostic Laboratories

Others

By Regional Outlook (Revenue – USD Million, 2020–2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

129 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Point of Care Lipid Test Market Insights
4.1. Point of Care Lipid Test Market – Market Snapshot
4.2. Point of Care Lipid Test Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Ageing Population
4.2.1.2. Rising Prevalence of Cardiovascular Diseases
4.2.2. Restraints and Challenges
4.2.2.1. High Initial Investment
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Point of Care Lipid Test Market Trends
4.6. Value Chain Analysis
5. Global Point of Care Lipid Test Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
5.3. Instruments
5.3.1. Global Point of Care Lipid Test Market, by Instruments, by Region, 2020–2034 (USD million)
5.4. Consumables
5.4.1. Global Point of Care Lipid Test Market, by Consumables, by Region, 2020–2034 (USD million)
6. Global Point of Care Lipid Test Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Global Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
6.3. Hyperlipidemia
6.3.1. Global Point of Care Lipid Test Market, by Hyperlipidemia, by Region, 2020–2034 (USD million)
6.4. Hypertriglyceridemia
6.4.1. Global Point of Care Lipid Test Market, by Hypertriglyceridemia, by Region, 2020–2034 (USD million)
6.5. Tangier Disease
6.5.1. Global Point of Care Lipid Test Market, by Tangier Disease, by Region, 2020–2034 (USD million)
6.6. Hyperlipoproteinemia
6.6.1. Global Point of Care Lipid Test Market, by Hyperlipoproteinemia, by Region, 2020–2034 (USD million)
6.7. Familial Hypercholesterolemia
6.7.1. Global Point of Care Lipid Test Market, by Familial Hypercholesterolemia, by Region, 2020–2034 (USD million)
6.8. Others
6.8.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020–2034 (USD million)
7. Global Point of Care Lipid Test Market, by Disease Indication
7.1. Key Findings
7.2. Introduction
7.2.1. Global Point of Care Lipid Test Market, by Medical Biotechnology, 2020-2034 (USD million)
7.3. Lipid and Lipoprotein Disorders
7.3.1. Global Point of Care Lipid Test Market, by Lipid and Lipoprotein Disorders, by Region, 2020–2034 (USD million)
7.4. Atherosclerosis
7.4.1. Global Point of Care Lipid Test Market, by Atherosclerosis, by Region, 2020–2034 (USD million)
7.5. Liver and Renal Diseases
7.5.1. Global Point of Care Lipid Test Market, by Liver and Renal Diseases, by Region, 2020–2034 (USD million)
7.6. Diabetes Mellitus
7.6.1. Global Point of Care Lipid Test Market, by Diabetes Mellitus, by Region, 2020–2034 (USD million)
7.7. Others
7.7.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020–2034 (USD million)
8. Global Point of Care Lipid Test Market, by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. Global Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
8.3. Hospitals
8.3.1. Global Point of Care Lipid Test Market, by Hospitals, by Region, 2020–2034 (USD million)
8.4. Clinics
8.4.1. Global Point of Care Lipid Test Market, by Clinics, by Region, 2020–2034 (USD million)
8.5. Research and Diagnostic Laboratories
8.5.1. Global Point of Care Lipid Test Market, by Research and Diagnostic Laboratories, by Region, 2020–2034 (USD million)
8.6. Others
8.6.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020–2034 (USD million)
9. Global Point of Care Lipid Test Market, by Geography
9.1. Key Findings
9.2. Introduction
9.2.1. Point of Care Lipid Test Market Assessment, By Geography, 2020-2034 (USD million)
9.3. Point of Care Lipid Test Market – North America
9.3.1. North America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.3.2. North America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.3.3. North America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.3.4. North America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.3.5. Point of Care Lipid Test Market – US
9.3.5.1. US: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.3.5.2. US: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.3.5.3. US: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.3.5.4. US: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.3.6. Point of Care Lipid Test Market – Canada
9.3.6.1. Canada: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.3.6.2. Canada: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.3.6.3. Canada: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.3.6.4. Canada: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.4. Point of Care Lipid Test Market – Europe
9.4.1. Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.4.2. Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.4.3. Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.4.4. Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.4.5. Point of Care Lipid Test Market – UK
9.4.5.1. UK: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.4.5.2. UK: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.4.5.3. UK: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.4.5.4. UK: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.4.6. Point of Care Lipid Test Market – France
9.4.6.1. France: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.4.6.2. France: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.4.6.3. France: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.4.6.4. France: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.4.7. Point of Care Lipid Test Market – Germany
9.4.7.1. Germany: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.4.7.2. Germany: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.4.7.3. Germany: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.4.7.4. Germany: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.4.8. Point of Care Lipid Test Market – Italy
9.4.8.1. Italy: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.4.8.2. Italy: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.4.8.3. Italy: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.4.8.4. Italy: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.4.9. Point of Care Lipid Test Market – Spain
9.4.9.1. Spain: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.4.9.2. Spain: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.4.9.3. Spain: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.4.9.4. Spain: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.4.10. Point of Care Lipid Test Market – Netherlands
9.4.10.1. Netherlands: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.4.10.2. Netherlands: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.4.10.3. Netherlands: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.4.10.4. Netherlands: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.4.11. Point of Care Lipid Test Market – Russia
9.4.11.1. Russia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.4.11.2. Russia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.4.11.3. Russia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.4.11.4. Russia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.4.12. Point of Care Lipid Test Market – Rest of Europe
9.4.12.1. Rest of Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.4.12.2. Rest of Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.4.12.3. Rest of Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.4.12.4. Rest of Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.5. Point of Care Lipid Test Market – Asia Pacific
9.5.1. Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.5.2. Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.5.3. Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.5.4. Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.5.5. Point of Care Lipid Test Market – China
9.5.5.1. China: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.5.5.2. China: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.5.5.3. China: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.5.5.4. China: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.5.6. Point of Care Lipid Test Market – India
9.5.6.1. India: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.5.6.2. India: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.5.6.3. India: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.5.6.4. India: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.5.7. Point of Care Lipid Test Market – Malaysia
9.5.7.1. Malaysia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.5.7.2. Malaysia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.5.7.3. Malaysia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.5.7.4. Malaysia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.5.8. Point of Care Lipid Test Market – Japan
9.5.8.1. Japan: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.5.8.2. Japan: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.5.8.3. Japan: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.5.8.4. Japan: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.5.9. Point of Care Lipid Test Market – Indonesia
9.5.9.1. Indonesia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.5.9.2. Indonesia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.5.9.3. Indonesia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.5.9.4. Indonesia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.5.10. Point of Care Lipid Test Market – South Korea
9.5.10.1. South Korea: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.5.10.2. South Korea: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.5.10.3. South Korea: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.5.10.4. South Korea: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.5.11. Point of Care Lipid Test Market – Australia
9.5.11.1. Australia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.5.11.2. Australia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.5.11.3. Australia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.5.11.4. Australia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.5.12. Point of Care Lipid Test Market – Rest of Asia Pacific
9.5.12.1. Rest of Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.5.12.2. Rest of Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.5.12.3. Rest of Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.5.12.4. Rest of Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.6. Point of Care Lipid Test Market – Middle East & Africa
9.6.1. Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.6.2. Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.6.3. Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.6.4. Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.6.5. Point of Care Lipid Test Market – Saudi Arabia
9.6.5.1. Saudi Arabia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.6.5.2. Saudi Arabia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.6.5.3. Saudi Arabia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.6.5.4. Saudi Arabia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.6.6. Point of Care Lipid Test Market – UAE
9.6.6.1. UAE: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.6.6.2. UAE: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.6.6.3. UAE: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.6.6.4. UAE: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.6.7. Point of Care Lipid Test Market – Israel
9.6.7.1. Israel: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.6.7.2. Israel: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.6.7.3. Israel: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.6.7.4. Israel: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.6.8. Point of Care Lipid Test Market – South Africa
9.6.8.1. South Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.6.8.2. South Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.6.8.3. South Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.6.8.4. South Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.6.9. Point of Care Lipid Test Market – Rest of Middle East & Africa
9.6.9.1. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.6.9.2. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.6.9.3. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.6.9.4. Rest of Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.7. Point of Care Lipid Test Market – Latin America
9.7.1. Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.7.2. Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.7.3. Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.7.4. Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.7.5. Point of Care Lipid Test Market – Mexico
9.7.5.1. Mexico: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.7.5.2. Mexico: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.7.5.3. Mexico: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.7.5.4. Mexico: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.7.6. Point of Care Lipid Test Market – Brazil
9.7.6.1. Brazil: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.7.6.2. Brazil: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.7.6.3. Brazil: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.7.6.4. Brazil: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.7.7. Point of Care Lipid Test Market – Argentina
9.7.7.1. Argentina: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.7.7.2. Argentina: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.7.7.3. Argentina: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.7.7.4. Argentina: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
9.7.8. Point of Care Lipid Test Market – Rest of Latin America
9.7.8.1. Rest of Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
9.7.8.2. Rest of Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
9.7.8.3. Rest of Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
9.7.8.4. Rest of Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Callegari Srl
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. F. Hoffmann-La Roche Ltd.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Menarini Group
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. MiCoBio
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Nova Biomedical
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. SD Biosensor, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Sinocare Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. VivaChek Biotech (Hangzhou) Co., Ltd.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us